Literature DB >> 16722834

The medicines for children agenda in the UK.

Terence Stephenson1.   

Abstract

Children can expect the medicines prescribed for them to have at least as good an evidence base as in adult practice. Current licensing arrangements in the UK ensure a rigorous assessment of most drugs used for adults, whereas prescribing outside the licence is relatively common for children. Until the evidence base is increased, consensus guidelines or formularies, such as the new British National Formulary for Children, provide some protection for children and prescribers. For the future, there is optimism that the dearth of research on which to base children's prescribing will be addressed by new initiatives, such as the UK Medicines for Children Research Network and draft EU legislation providing incentives to industry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722834      PMCID: PMC1885111          DOI: 10.1111/j.1365-2125.2006.02676.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Birth of a formulary.

Authors:  P S Hull
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

2.  Unlicensed and off label prescribing of drugs in general practice.

Authors:  J McIntyre; S Conroy; A Avery; H Corns; I Choonara
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

3.  Implications of the Crown Report and nurse prescribing.

Authors:  T Stephenson
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

4.  Unlicensed and off label drug use in neonates.

Authors:  S Conroy; J McIntyre; I Choonara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

Review 5.  Efficacy and safety of antidepressants for children and adolescents.

Authors:  Jon N Jureidini; Christopher J Doecke; Peter R Mansfield; Michelle M Haby; David B Menkes; Anne L Tonkin
Journal:  BMJ       Date:  2004-04-10

6.  Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Authors:  S Turner; A Gill; T Nunn; B Hewitt; I Choonara
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321

7.  Off label and unlicensed drug use among French office based paediatricians.

Authors:  M Chalumeau; J M Tréluyer; B Salanave; R Assathiany; G Chéron; N Crocheton; C Rougeron; M Mares; G Bréart; G Pons
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

Review 8.  How children's responses to drugs differ from adults.

Authors:  Terence Stephenson
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

9.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

Review 10.  Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.

Authors:  Craig J Whittington; Tim Kendall; Peter Fonagy; David Cottrell; Andrew Cotgrove; Ellen Boddington
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

View more
  4 in total

1.  Prospective observational study of adverse drug reactions to diclofenac in children.

Authors:  Joseph F Standing; Kuan Ooi; Simon Keady; Richard F Howard; Imogen Savage; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 2.  Reported paediatric adverse drug reactions in the UK 2000-2009.

Authors:  Daniel B Hawcutt; Pramod Mainie; Andrew Riordan; Rosalind L Smyth; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

3.  Medicine use practices in management of symptoms of acute upper respiratory tract infections in children (≤12 years) in Kampala city, Uganda.

Authors:  Moses Ocan; Mary Aono; Clare Bukirwa; Emmanuel Luyinda; Cathy Ochwo; Elastus Nsambu; Stella Namugonza; Joseph Makoba; Enock Kandaruku; Hannington Muyende; Aida Nakawunde
Journal:  BMC Public Health       Date:  2017-09-21       Impact factor: 3.295

4.  What parents of children who have received emergency care think about deferring consent in randomised trials of emergency treatments: postal survey.

Authors:  Carrol Gamble; Simon Nadel; Dee Snape; Andrew McKay; Helen Hickey; Paula Williamson; Linda Glennie; Claire Snowdon; Bridget Young
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.